Article
Cross-Resistance of clinical isolates of Candida albicans and Candida glabrata to over-the-counter azoles used in the treatment of vaginitis.
Microbial drug resistance (Larchmont, N.Y.) - 1 Jan 2000
Cross E W, Park S, Perlin D S
Abstract excerpt
Antifungal drug resistance in Candida spp. continues to increase in response to the widespread application of triazole therapeutics among immunosuppressed patients. Azole-based over-the-counter (OTC) antifungal agents used to treat vaginitis have the potential to exacerbate this problem by contributing to the selection of highly resistant strains of Candida in otherwise healthy women. In this study, we show that...
Topics
- Antifungal Agents
- Azoles
- Candida
- Candida albicans
- Candidiasis
- Candidiasis, Vulvovaginal
- Drug Resistance, Microbial
- Female
- Fungemia
- Humans
- Immunocompromised Host
